Patents by Inventor Ruben Henricus Carolus Adrianus Titus LELIEVELD

Ruben Henricus Carolus Adrianus Titus LELIEVELD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid forms of a plasma kallikrein inhibitor and salts thereof
    Patent number: 11584735
    Abstract: New solid forms of the plasma kallikrein inhibitor, 1-({4-[(5-fluoro-2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)pyrazole-4-carboxamide and its salts, are described.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: February 21, 2023
    Assignee: KalVista Pharmaceuticals Limited
    Inventors: David Malcolm Crowe, Edwin Aret, Kiran Gandhi, Ruben Henricus Carolus Adrianus Titus Lelieveld, Emma Kay Sharp, Richard Simon Todd
  • SOLID FORMS OF A PLASMA KALLIKREIN INHIBITOR AND SALTS THEREOF
    Publication number: 20210171496
    Abstract: New solid forms of the plasma kallikrein inhibitor, 1-({4-[(5-fluoro-2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)pyrazole-4-carboxamide and its salts, are described.
    Type: Application
    Filed: November 29, 2018
    Publication date: June 10, 2021
    Inventors: David Malcolm CROWE, Stephen Mark MACDONALD-BROWN, Edwin ARET, Kiran GANDHI, Ruben Henricus Carolus Adrianus Titus LELIEVELD, Emma Kay SHARP, Richard Simon TODD